Insys Therapeutics, Inc. to Present at 2017 RBC Capital Markets Global Healthcare Conference
February 14 2017 - 4:30PM
Insys Therapeutics, Inc. (“Insys” or “the Company”) (NASDAQ:INSY)
today announced that Santosh Vetticaden, MD, PhD, Interim Chief
Executive Officer, and Chief Medical Officer, and Darryl Baker,
Chief Financial Officer, will present at the 2017 RBC Capital
Markets Global Healthcare Conference as follows:
Date: |
Thursday, February 23, 2017 |
Time: |
1:35
p.m. Eastern Standard Time |
Location: |
The
New York Palace |
The presentation will be webcast live at the aforementioned time
as well as archived for 90 days thereafter, via the Company’s
website at www.insysrx.com, under the Investors Section or at
http://www.veracast.com/webcasts/rbc/healthcare2017/21210290235.cfm.
About Insys Therapeutics, Inc. Insys
Therapeutics is a specialty pharmaceutical company that develops
and commercializes innovative drugs and novel drug delivery systems
of therapeutic molecules that improve the quality of life of
patients.
Investor Contact:
Lisa M. Wilson
Email: lwilson@insitecony.com
INSYS THERAPEUTICS, INC. (NASDAQ:INSY)
Historical Stock Chart
From Apr 2024 to May 2024
INSYS THERAPEUTICS, INC. (NASDAQ:INSY)
Historical Stock Chart
From May 2023 to May 2024